![Jason Haas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Haas
Director of Finance/CFO at
ODYSSEY THERAPEUTICS, INC.
Net worth: 2 M $ as of 31/05/2026
Profile
Jason Haas is currently an Independent Director at Ligand Pharmaceuticals, Inc. since 2022 and Chief Financial Officer at Odyssey Therapeutics, Inc. since 2024.
Formerly, Mr. Haas was Chief Financial Officer at Syros Pharmaceuticals, Inc. from 2021 to 2024, Co-Head-Americas & Healthcare Investment Banking at Barclays PLC from 2016 to 2021, Head-Americas & Healthcare Investment Banking at Deutsche Bank AG from 2012 to 2016, and Managing Director at Goldman Sachs & Co. LLC.
Education includes an undergraduate degree from Colgate University and an MBA from Columbia Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/06/2026 | 4,981 ( 0.02% ) | 1 M $ | 31/05/2026 | |
| 08/05/2026 | 62,908 ( 0.13% ) | 1 M $ | 31/05/2026 |
Jason Haas active positions
| Companies | Position | Start |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 29/06/2022 |
| ODYSSEY THERAPEUTICS, INC. | Director of Finance/CFO | 01/12/2024 |
Former positions of Jason Haas
| Companies | Position | End |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Director of Finance/CFO | 22/11/2024 |
| BARCLAYS PLC | Corporate Officer/Principal | 01/10/2021 |
| DEUTSCHE BANK AG | Corporate Officer/Principal | 01/06/2016 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Training of Jason Haas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Deutsche Bank AG
 Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
Barclays PLC
 Barclays PLC Investment Banks/BrokersFinance Operates as a bank holding company whose subsidiaries engages in retail banking, credit cards, corporate and investment banking and wealth management services | Finance |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Jason Haas
